Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.
about
Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusionA Fatal Case of Immune Hyperhemolysis with Bone Marrow Necrosis in a Patient with Sickle Cell Disease.Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.Stem cell-derived erythrocytes as upcoming players in blood transfusion.Alternative blood products and clinical needs in transfusion medicineRed blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.Hyperhemolysis syndrome in sickle cell disease.A mild acute hemolytic transfusion reaction in a patient with alloanti-Ge3: a case report and review of the literature.Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing.Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease.Hyperhemolysis Syndrome without Underlying Hematologic Disease.Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.How we incorporate molecular typing of donors and patients into our hospital transfusion service.Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.Delayed hemolytic transfusion reaction, intravenous immunoglobulin, and rituximab.Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease.Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report.Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions.Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors
P2860
Q26825749-BB8B61E8-1DB5-47D6-9A24-4FC28BD54B0BQ33440070-FCD2460B-3B6A-487A-A107-B5D3059A3E99Q33886869-F4D194BB-7671-4C01-A91B-390CE16DE22BQ35672198-D0459334-DBB0-48C9-A80C-327CA2B5B4BEQ35897250-1A533CA4-7BE5-486A-9ED0-4AD729D36945Q35915095-2645E7FD-A707-42FE-8FB0-84516060A208Q36106307-316CE0C1-2ABF-4C5C-AD7C-F3700BDA85A1Q37044218-389FF7AA-98C8-484A-9ED3-538550E17A81Q37810262-418F1C0C-BD2C-4A2A-859F-429F2AA352D9Q37851550-AA7A4AAC-9181-4B67-90AC-FD43618FDF73Q38151829-EA0C20E2-8DD8-4ADD-9B56-D61C7AFA09CBQ38666286-677A6901-4500-4D2C-9AE2-5851D6F54976Q38949082-847242DB-D38F-44B6-A6A8-B0369D63B645Q39762537-C65C7D21-DBDF-4D75-B0CC-A29815539F5FQ41199253-673E0600-D70E-4F25-B9E4-6F4928FD74C8Q41725805-F5CC7C53-E7BA-46A4-A12E-56E22D14B706Q44479896-A6BD17B6-98CC-49A1-B9EB-930D3525FA3CQ44980055-58DF746C-EBDD-4015-993B-1C87B0CED39BQ46141398-9F83F2CA-D77C-4B32-B723-3A459D48400EQ48326469-35ACD588-ED6F-4754-85D1-A029B2A2CBCCQ50218898-3E50F57D-A59D-4B6C-88D6-784AB72317CDQ50241611-8E79E6C2-70DA-4127-806C-3632185EAFE8Q50437265-0FDA92CB-12B1-42DF-B6EF-C4BDBD0C7DE0Q50445091-71B81553-E766-4C51-A3B3-77381DFE5501Q50459628-0C9FCF66-FC07-4B8B-AE52-AE3416E1959FQ50519275-791869D3-AB68-4971-84BC-EEEEBF394726Q51654073-794A66E8-D062-42BF-B97B-4CC7E2FD324EQ51678751-48017007-9703-45D6-8D9A-5CD1ECDC3FBBQ53686375-683527B2-2E10-4D15-9A11-FE7D7D382A94Q57142932-25691FF1-774B-4A73-8660-511926B5BDFC
P2860
Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hyperhemolysis syndrome in sic ...... pisode) and literature review.
@en
Hyperhemolysis syndrome in sickle cell disease: case report
@nl
type
label
Hyperhemolysis syndrome in sic ...... pisode) and literature review.
@en
Hyperhemolysis syndrome in sickle cell disease: case report
@nl
prefLabel
Hyperhemolysis syndrome in sic ...... pisode) and literature review.
@en
Hyperhemolysis syndrome in sickle cell disease: case report
@nl
P2093
P2860
P1433
P1476
Hyperhemolysis syndrome in sic ...... pisode) and literature review.
@en
P2093
P2860
P304
P356
10.1111/J.1537-2995.2008.01693.X
P577
2008-03-25T00:00:00Z